These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35318031)

  • 1. Qualitative High-Throughput Analysis of Subvisible Particles in Biological Formulations Using Backgrounded Membrane Imaging.
    Murphy MI; Bruque M; Hanford A; Trayton I; Handali M; Leissa JA; Hasige S; Day K; Patel SM
    J Pharm Sci; 2022 Jun; 111(6):1605-1613. PubMed ID: 35318031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
    Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
    J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation, Characterization and Discriminant Analysis of Subvisible Particles in Biologics Formulations.
    Akhunzada ZS; Hubert M; Sahin E; Pratt J
    Curr Pharm Biotechnol; 2019; 20(3):232-244. PubMed ID: 30767738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of background membrane imaging versus flow technologies for subvisible particle analysis of biologics.
    Vargas SK; Eskafi A; Carter E; Ciaccio N
    Int J Pharm; 2020 Mar; 578():119072. PubMed ID: 32001293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.
    Werk T; Volkin DB; Mahler HC
    Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-flow imaging multi-instrument evaluation for sub-visible particle detection.
    Fawaz I; Schaz S; Boehrer A; Garidel P; Blech M
    Eur J Pharm Biopharm; 2023 Apr; 185():55-70. PubMed ID: 36708971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.
    Nishi H; Mathäs R; Fürst R; Winter G
    J Pharm Sci; 2014 Jan; 103(1):90-9. PubMed ID: 24218205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subvisible Particle Analysis of 17 Monoclonal Antibodies Approved in China Using Flow Imaging and Light Obscuration.
    Guo S; Yu C; Guo X; Jia Z; Yu X; Yang Y; Guo L; Wang L
    J Pharm Sci; 2022 Apr; 111(4):1164-1171. PubMed ID: 34551350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles.
    Calderon CP; Krhač Levačić A; Helbig C; Wuchner K; Menzen T
    J Pharm Sci; 2022 Sep; 111(9):2422-2434. PubMed ID: 35661758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.
    Kalonia C; Kumru OS; Prajapati I; Mathaes R; Engert J; Zhou S; Middaugh CR; Volkin DB
    J Pharm Sci; 2015 Feb; 104(2):536-47. PubMed ID: 25302696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring Subvisible Particles in Protein Formulations Using a Modified Light Obscuration Sensor with Improved Detection Capabilities.
    Ríos Quiroz A; Québatte G; Stump F; Finkler C; Huwyler J; Schmidt R; Mahler HC; Koulov AV; Adler M
    Anal Chem; 2015 Jun; 87(12):6119-24. PubMed ID: 26001042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Strengths of Total Holographic Video Microscopy in Detecting Sub-Visible Protein Particles in Biopharmaceuticals: A Comparison to Flow Imaging and Resonant Mass Measurement.
    Rahn H; Oeztuerk M; Hentze N; Junge F; Hollmann M
    J Pharm Sci; 2023 Apr; 112(4):985-990. PubMed ID: 36596393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Dimensional Homodyne Light Detection (3D-HLD) for High-Throughput Submicron Particle Analysis in (Highly Concentrated) Protein Biopharmaceuticals, Viral Vectors, and LNPs.
    Brandstetter D; Helbig C; Osawa K; Minemura H; Anzai Y; Torisu T; Uchiyama S; Menzen T; Friess W; Hawe A
    J Pharm Sci; 2024 Apr; 113(4):891-899. PubMed ID: 37926233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium.
    Kiyoshi M; Shibata H; Harazono A; Torisu T; Maruno T; Akimaru M; Asano Y; Hirokawa M; Ikemoto K; Itakura Y; Iwura T; Kikitsu A; Kumagai T; Mori N; Murase H; Nishimura H; Oda A; Ogawa T; Ojima T; Okabe S; Saito S; Saitoh S; Suetomo H; Takegami K; Takeuchi M; Yasukawa H; Uchiyama S; Ishii-Watabe A
    J Pharm Sci; 2019 Feb; 108(2):832-841. PubMed ID: 30121316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products.
    Zhang L; Shi S; Antochshuk V
    J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable Threshold Method for Determining the Boundaries of Imaged Subvisible Particles.
    Cavicchi RE; Collett C; Telikepalli S; Hu Z; Carrier M; Ripple DC
    J Pharm Sci; 2017 Jun; 106(6):1499-1507. PubMed ID: 28209364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning image analysis models pretrained on daily objects are useful for the preliminary characterization of particulate pharmaceutical samples.
    Salami H; Wood C; Ouyang H; Zhao X; Skomski D
    Biotechnol Bioeng; 2023 Aug; 120(8):2175-2185. PubMed ID: 37435969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative laser diffraction method for the assessment of protein subvisible particles.
    Totoki S; Yamamoto G; Tsumoto K; Uchiyama S; Fukui K
    J Pharm Sci; 2015 Feb; 104(2):618-26. PubMed ID: 25449441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmasking translucent protein particles by improved micro-flow imaging™ algorithms.
    Pedersen JS; Persson M
    J Pharm Sci; 2014 Jan; 103(1):107-14. PubMed ID: 24281987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening techniques for monitoring the sub-visible particle formation of free fatty acids in biopharmaceuticals.
    Chen W; Klemm D; Gregoritza K; Satya Krishna Kishore R; Olaf Stracke J; Wurth C; Pinto C; Sancho Oltra N
    Eur J Pharm Biopharm; 2023 Sep; 190():242-247. PubMed ID: 37524212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.